Walmart's market capitalization is estimated at $635.5 billion as of September 2024, making it the 13th most valuable company in the world. The partnership will give CBD Life Sciences unprecedented exposure on a global retail platform.
SCOTTSDALE, AZ / ACCESSWIRE / September 24, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in innovative cannabidiol products, is pleased to announce the launch of its flagship product line on the Walmart Marketplace. This milestone marks a major leap in the company's retail strategy and is poised to drive significant revenue growth and expand its market reach to millions of potential customers.
Key highlights:
Market Expansion: Entering the Walmart Marketplace provides access to one of the world's largest retail platforms with over 120 million monthly visitors, strategically positioning CBDL to significantly expand its brand awareness and consumer base.
Increased Revenue: Initial projections indicate that this new distribution channel will significantly increase revenue, with annual sales increasing by 35%. Revenue growth has already increased by 20% over the past 12 months, and we expect this expansion to accelerate growth.
Walmart Product Line: Initial products include best-selling Nano CBD Coffee Creamer, Mellow Morning and CBD Pain Cream, which have seen growing demand in the local market. These products have been praised for their effectiveness and will now be distributed nationally, expanding our customer base across the United States.
Investor impact: This move will create new revenue streams that will enhance shareholder value. By diversifying sales channels, the company aims to increase gross profit by 10% in the next financial year, further enhancing returns to investors.
A proven path to growth
“As a small but fast-growing company, we know that entering a high-traffic market like Walmart will be a powerful catalyst for our expansion. We continue to prioritize innovation in our product line and have received positive feedback from both consumers and local retailers. With our products now in the Walmart Marketplace, we expect a stronger competitive advantage and a larger footprint in the fast-growing CBD sector, which is projected to reach $47.22 billion by 2028.”
CEO Statement
“Entering the Walmart Marketplace is an exciting step in our growth strategy,” said Lisa Nelson, CEO of CBD Life Sciences, Inc. “Not only are we expanding our reach, but we are also strengthening our ability to deliver value to our investors. The CBD market is poised for explosive growth, and this new distribution channel strategically positions us to capitalize on growing consumer demand.”
Future-proof growth
CBD Life Sciences will continue to focus on pursuing additional strategic partnerships and launching new products as the business expands. Focus on innovation, efficiency and expanding into new revenue streams is critical to maximizing shareholder value.
About CBD Life Sciences, Inc.
CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. CBD Vault develops and retails/wholesales a full line of cannabidiol-based and organic products, including Delta 8 and 10 gummies, full spectrum tinctures and gummies, pain relief creams, roll-ons, ointments, a full pet line, pre-rolls, a full line of spa products, sleep and anxiety relief edibles, etc. CBD Vault's products can be viewed and purchased on the company's website at www.thecbdvault.com.
Follow us on social media for the latest updates.
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Inquiries: (email protected)
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. Please see CBD Life Sciences, Inc.'s filings with the OTC Markets, which describe certain factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release contains forward-looking statements that reflect management's current expectations based on certain assumptions. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These factors include general global economic conditions, general industry and market conditions, sector changes and growth rates, uncertainty as to whether our strategy and business plans will generate the expected benefits, increased competition, availability and cost of capital, our ability to identify, develop and achieve commercial success, the level of expenditures required to maintain and improve the quality of our services, changes in the economy, laws and regulations, including codes and standards, intellectual property rights, tax matters, or other issues that are not anticipated, our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements regarding its ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
contact address
Lisa Nelson
CEO
(email address protected)
4802091720
Source: CBD Life Sciences Inc.
